NCT00627536View on ClinicalTrials.gov

Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Cicatrix
Interventions
DRUG

Avotermin

A single intradermal injection of avotermin administered at the dose to both margins of a full-thickness incision immediately following closure.

DRUG

Placebo

Matched to avotermin dosage strength

Trial Locations (1)

M139XX

Renovo Clinical Trials Unit, Manchester

All Listed Sponsors
lead

Renovo

INDUSTRY

NCT00627536 - Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions | Biotech Hunter | Biotech Hunter